Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Document › Details

Bayer AG. (6/5/23). "Press Release: Bayer Strengthens Gene Therapy Portfolio with Lipid Nanoparticle Technology from Acuitas Therapeutics [Not intended for U.S. and UK Media]". Berlin.

	Organisation	Asklepios BioPharmaceutical Inc. (AskBio)
	Group	Bayer (Group)
	Organisation 2	Acuitas Therapeutics Inc.
	Product	lipid nanoparticle technology (LNP technology)
	Product 2	RNA-based therapeutic
	Index term	Bayer–Acuitas Therapeutics: LNP technology, 202306– collab €na using LNP technology to deliver RNA payloads to liver
	Person	Janus, Friedemann (Bayer 202306 acting Head of Business Development + Licewnsing/Open Innvation for Pharma Div)
	Person 2	Madden, Thomas (Tom) (Acuitas Therapeutics 202306 CEO)

Original document
accessed by [iito] on 2023-06-06

Record changed: 2024-01-20

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

More documents for Bayer (Group)

[1] Roivant Sciences GmbH. (9/10/24). "Press Release: Roivant Unveils New Pipeline Program Mosliciguat, a Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator". Basel, London & New York, NY....
[2] NextRNA Therapeutics, Inc.. (8/28/24). "Press Release: Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-coding RNAs (lncRNAs) in Oncology". Berlin & Boston, MA....
[3] BlueRock Therapeutics LP. (5/30/23). "Press Release: BlueRock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Cell Therapy Candidate Bemdaneprocel". Berlin & Cambridge, MA....
[4] WhiteLab Genomics. (5/6/24). "Press Release: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab and Ginkgo Bioworks’ Technology Network". Cambridge, MA....
[5] CRISPR Therapeutics AG. (3/13/24). "Press Release: CRISPR Therapeutics Proposes New Appointment to the Board of Directors". Zug & Boston, MA....
[6] BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London....
[7] Bayer AG. (10/10/23). "Press Release: Bayer Invests 250 million USD in New Cell Therapy Manufacturing Facility in the U.S. [Not intended for US and UK Media]". Berlin....
[8] Twist Bioscience Corporation. (10/5/23). "Press Release: Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million". Hamburg & Singapore....
[9] Bayer AG. (9/21/23). "Press Release: Bayer to Collaborate with Hologic in Breast cancer Imaging [Not intended for U.S. and UK Media]". Berlin....
[10] Bayer AG. (8/30/23). "Press Release: Strong Commitment to Modern Crop Protection Made in Europe. Bayer to Invest EUR 220 Million in New R&D Facility at Its Monheim Site". Monheim....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]